CoChat

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers

Granados, D P, Rodenbrock, A, Laverdure, J-P, Côté, C, Caron-Lizotte, O, Carli, C, Pearson, H, Janelle, V, Durette, C, Bonneil, E, Roy, D C, Delisle, J-S, Lemieux, S, Thibault, P, Perreault, C · 2016 · Leukemia
Cited by 51

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/leu.2016.22

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 56

  1. Schumacher TN, Schreiber RD . Neoantigens in cancer immunotherapy. Science 2015; 348: 69–74. · DOI · Paper page
  2. Rosenberg SA, Restifo NP . Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348: 62–68. · DOI · Paper page
  3. Sharma P, Allison JP . The future of immune checkpoint therapy. Science 2015; 348: 56–61. · DOI · Paper page
  4. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368: 1509–1518. · DOI · Paper page
  5. Maus MV, Fraietta JA, Levine BL, Kalos M, Zhao Y, June CH . Adoptive immunotherapy for cancer or viruses. Annu Rev Immunol 2014; 32: 189–225. · DOI · Paper page
  6. Maus MV, Grupp SA, Porter DL, June CH . Antibody modified T cells: CARs take the front seat for hematologic malignancies. Blood 2014; 123: 2625–2635. · DOI · Paper page
  7. Reddy P, Maeda Y, Liu C, Krijanovski OI, Korngold R, Ferrara JL . A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 2005; 11: 1244–1249. · DOI · Paper page
  8. Vincent K, Roy DC, Perreault C . Next-generation leukemia immunotherapy. Blood 2011; 118: 2951–2959. · DOI
  9. Mutis T, Brand R, Gallardo D, van BA, Niederwieser D, Goulmy E . Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients. Leukemia 2010; 24: 1388–1392. · doi:10.1038/leu.2010.115
  10. Jenq RR, van den Brink MR . Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer 2010; 10: 213–221. · DOI · Paper page
  11. Roopenian D, Choi EY, Brown A . The immunogenomics of minor histocompatibility antigens. Immunol Rev 2002; 190: 86–94. · DOI
  12. Mullally A, Ritz J . Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 2007; 109: 1355–1362. · DOI
  13. Granados DP, Laumont CM, Thibault P, Perreault C . The nature of self for T cells - a systems-level perspective. Curr Opin Immunol 2015; 34: 1–8. · DOI
  14. Warren EH, Zhang XC, Li S, Fan W, Storer BE, Chien JW et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood 2012; 120: 2796–2806. · DOI
  15. Blazar BR, Murphy WJ, Abedi M . Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12: 443–458. · DOI · Paper page
  16. Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C . Adoptive transfer of T lymphocytes targeted to a single immunodominant minor histocompatibility antigen eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001; 7: 789–794. · DOI · Paper page
  17. Meunier MC, Delisle JS, Bergeron J, Rineau V, Baron C, Perreault C . T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med 2005; 11: 1222–1229. · DOI
  18. Li N, Matte-Martone C, Zheng H, Cui W, Venkatesan S, Tan HS et al. Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improves GVL and immune reconstitution. Blood 2011; 118: 5965–5976. · DOI
  19. Blankenstein T, Leisegang M, Uckert W, Schreiber H . Targeting cancer-specific mutations by T cell receptor gene therapy. Curr Opin Immunol 2015; 33: 112–119. · DOI · Paper page
  20. Schreiber RD, Old LJ, Smyth MJ . Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565–1570. · DOI · Paper page
  21. Spierings E, Hendriks M, Absi L, Canossi A, Chhaya S, Crowley J et al. Phenotype frequencies of autosomal minor histocompatibility antigens display significant differences among populations. PLoS Genet 2007; 3: e103. · doi:10.1371/journal.pgen.0030103
  22. Bleakley M, Riddell SR . Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia. Immunol Cell Biol 2011; 89: 396–407. · DOI
  23. Hombrink P, Hassan C, Kester MG, Jahn L, Pont MJ, de Ru AH et al. Identification of biological relevant minor histocompatibility antigens within the B-lymphocyte-derived HLA-ligandome using a reverse immunology approach. Clin Cancer Res 2015; 21: 2177–2186. · doi:10.1158/1078-0432.ccr-14-2188
  24. Van Bergen CA, Rutten CE, Van Der Meijden ED, Van Luxemburg-Heijs SA, Lurvink EG, Houwing-Duistermaat JJ et al. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res 2010; 70: 9073–9083. · DOI
  25. Granados DP, Sriranganadane D, Daouda T, Zieger A, Laumont CM, Caron-Lizotte O et al. Impact of genomic polymorphism on the repertoire of human MHC class I-associated peptides. Nat Commun 2014; 5: 3600. · DOI
  26. Dolan BP, Sharma AA, Gibbs JS, Cunningham TJ, Bennink JR, Yewdell JW . MHC class I antigen processing distinguishes endogenous antigens based on their translation from cellular vs. viral mRNA. Proc Natl Acad Sci USA 2012; 109: 7025–7030. · DOI
  27. Yewdell JW . DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 2011; 32: 548–558. · DOI · Paper page
  28. Nesvizhskii AI . Proteogenomics: concepts, applications and computational strategies. Nat Methods 2014; 11: 1114–1125. · DOI · Paper page
  29. Wolfl M, Greenberg PD . Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat Protoc 2014; 9: 950–966. · DOI
  30. Janelle V, Carli C, Taillefer J, Orio J, Delisle JS . Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture. J Transl Med 2015; 13: 123. · DOI
  31. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA et al. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061–1073. · DOI · Paper page
  32. Spierings E . Minor histocompatibility antigens: past, present, and future. Tissue Antigens 2014; 84: 374–60. · DOI · Paper page
  33. Majewski J, Ott J . Distribution and characterization of regulatory elements in the human genome. Genome Res 2002; 12: 1827–1836. · DOI · Paper page
  34. Asakura S, Hashimoto D, Takashima S, Sugiyama H, Maeda Y, Akashi K et al. Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. J Clin Invest 2010; 120: 2370–2378. · DOI
  35. Flutter B, Edwards N, Fallah-Arani F, Henderson S, Chai JG, Sivakumaran S et al. Nonhematopoietic antigen blocks memory programming of alloreactive CD8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation. J Clin Invest 2010; 120: 3855–3868. · DOI
  36. Fortier MH, Caron E, Hardy MP, Voisin G, Lemieux S, Perreault C et al. The MHC class I peptide repertoire is molded by the transcriptome. J Exp Med 2008; 205: 595–610. · DOI · Paper page
  37. Hoof I, van Baarle D, Hildebrand WH, Kesmir C . Proteome sampling by the HLA class I antigen processing pathway. PLoS Comput Biol 2012; 8: e1002517. · DOI
  38. Granados DP, Yahyaoui W, Laumont CM, Daouda T, Muratore-Schroeder TL, Cote C et al. MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood 2012; 119: e181–e191. · DOI
  39. Caron E, Vincent K, Fortier MH, Laverdure JP, Bramoullé A, Hardy MP et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 2011; 7: 533. · DOI · Paper page
  40. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620–625. · DOI · Paper page
  41. Chappell P, Meziane EK, Harrison M, Magiera L, Hermann C, Mears L et al. Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding. Elife 2015; 4: e05345. · DOI · Paper page
  42. Schellens IM, Hoof I, Meiring HD, Spijkers SN, Poelen MC, van Gaans-van den Brink JA et al. Comprehensive analysis of the naturally processed peptide repertoire: differences between HLA-A and B in the immunopeptidome. PLoS One 2015; 10: e0136417. · DOI
  43. Caron E, Espona L, Kowalewski DJ, Schuster H, Ternette N, Alpizar A et al. An open-source computational and data resource to analyze digital maps of immunopeptidomes. Elife 2015; 4: e07661. · DOI
  44. Heath WR, Carbone FR . The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nat Immunol 2013; 14: 978–985. · DOI · Paper page
  45. Bollard CM, Barrett AJ . Cytotoxic T lymphocytes for leukemia and lymphoma. Hematol Am Soc Hematol Educ Program 2014; 2014: 565–569. · DOI
  46. Yee C . The use of endogenous T cells for adoptive transfer. Immunol Rev 2014; 257: 250–263. · DOI
  47. Perreault C, Roy DC, Fortin C . Immunodominant minor histocompatibility antigens: the major ones. Immunol Today 1998; 19: 69–74. · doi:10.1016/s0167-5699(97)01185-7
  48. Choi EY, Christianson GJ, Yoshimura Y, Jung N, Sproule TJ, Malarkannan S et al. Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease. Blood 2002; 100: 4259–4264. · DOI
  49. Kim J, Ryu SJ, Oh K, Ju JM, Jeon JY, Nam G et al. Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help. Nat Commun 2015; 6: 7994. · DOI
  50. Rosinski SL, Stone B, Graves SS, Fuller DH, De Rosa SC, Spies GA et al. Development of a minor histocompatibility antigen vaccine regimen in the canine model of hematopoietic cell transplantation. Transplantation 2015; 99: 2083–2094. · DOI
  51. Turtle CJ, Riddell SR . Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy. Curr Opin Immunol 2011; 23: 299–305. · DOI
  52. Nauerth M, Weissbrich B, Knall R, Franz T, Dossinger G, Bet J et al. TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer. Sci Transl Med 2013; 5: 192ra87. · DOI
  53. Ghosh A, Holland AM, van den Brink MR . Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers. Immunol Rev 2014; 257: 226–236. · DOI
  54. June CH, Riddell SR, Schumacher TN . Adoptive cellular therapy: a race to the finish line. Sci Transl Med 2015; 7: 280ps7. · DOI · Paper page
  55. Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y et al. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood 2013; 122: 1341–1349. · DOI · Paper page
  56. Inaguma Y, Akahori Y, Murayama Y, Shiraishi K, Tsuzuki-Iba S, Endoh A et al. Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H. Gene Ther 2014; 21: 575–584. · DOI

Cited by

See all 51

Metadata

Authors
Granados, D. P., Rodenbrock, A., Laverdure, J.-P., Côté, C., Caron-Lizotte, O., Carli, C., Pearson, H., Janelle, V, Durette, C., Bonneil, E., Roy, D. C., Delisle, J.-S., Lemieux, S., Thibault, P., & Perreault, C.
Venue
Leukemia
Published
2016-02-09
Volume
30
Issue
6
Pages
1344-1354
ISSN
  • 0887-6924
  • 1476-5551
Cited by
51
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers. https://app.cochat.ai/papers/10.1038/leu.2016.22
The paper
Granados, D. P., Rodenbrock, A., Laverdure, J.-P., Côté, C., Caron-Lizotte, O., Carli, C., Pearson, H., Janelle, V, Durette, C., Bonneil, E., Roy, D. C., Delisle, J.-S., Lemieux, S., Thibault, P., & Perreault, C. (2016). Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers. Leukemia. https://doi.org/10.1038/leu.2016.22

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.